|
US10441654B2
(en)
|
2014-01-24 |
2019-10-15 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
SMC combination therapy for the treatment of cancer
|
|
US9732154B2
(en)
|
2014-02-28 |
2017-08-15 |
Janssen Biotech, Inc. |
Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
|
|
US9603927B2
(en)
|
2014-02-28 |
2017-03-28 |
Janssen Biotech, Inc. |
Combination therapies with anti-CD38 antibodies
|
|
PE20170676A1
(es)
|
2014-09-09 |
2017-05-22 |
Janssen Biotech Inc |
Terapias de combinacion con anticuerpos anti-cd38
|
|
EA202092609A1
(ru)
|
2014-12-04 |
2021-10-29 |
Янссен Байотек, Инк. |
Антитела к cd38 для лечения острого миелолейкоза
|
|
CA2986594C
(en)
|
2015-05-20 |
2025-06-10 |
Tufts Medical Center, Inc. |
Anti-CD38 antibodies for the treatment of light chain amyloidosis and other CD38-positive hematological malignancies
|
|
CN107708734B
(zh)
|
2015-06-22 |
2022-01-11 |
詹森生物科技公司 |
用抗cd38抗体和生存素抑制剂联合治疗血红素恶性肿瘤
|
|
HRP20240338T1
(hr)
*
|
2015-06-24 |
2024-05-24 |
Janssen Biotech, Inc. |
Imunomodulacija i liječenje solidnih tumora s protutijelima koja se specifično vežu na cd38
|
|
US20170044265A1
(en)
|
2015-06-24 |
2017-02-16 |
Janssen Biotech, Inc. |
Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38
|
|
CN116059219A
(zh)
|
2015-07-16 |
2023-05-05 |
比奥克斯塞尔医疗股份有限公司 |
一种使用免疫调节治疗癌症的新颖方法
|
|
HUE053366T2
(hu)
|
2015-11-03 |
2021-06-28 |
Janssen Biotech Inc |
Szubkután anti-CD38-ellenanyag-készítmények és alkalmazásuk
|
|
US10781261B2
(en)
|
2015-11-03 |
2020-09-22 |
Janssen Biotech, Inc. |
Subcutaneous formulations of anti-CD38 antibodies and their uses
|
|
US11027021B2
(en)
|
2016-03-15 |
2021-06-08 |
Seagen Inc. |
Combinations of PBD-based antibody drug conjugates with Bcl-2 inhibitors
|
|
US11110179B2
(en)
|
2016-06-03 |
2021-09-07 |
Seagen Inc. |
Combination of CD33 antibody drug conjugates with chemotherapeutic agents
|
|
EP3469001A4
(en)
|
2016-06-09 |
2020-05-06 |
Seattle Genetics, Inc. |
COMBINATIONS OF PBD-BASED ANTIBODY CONJUGATES WITH FLT3 INHIBITORS
|
|
US20190233533A1
(en)
|
2016-06-28 |
2019-08-01 |
Umc Utrecht Holding B.V. |
Treatment Of IgE-Mediated Diseases With Antibodies That Specifically Bind CD38
|
|
CN111565751A
(zh)
|
2017-10-31 |
2020-08-21 |
詹森生物科技公司 |
治疗高危多发性骨髓瘤的方法
|
|
WO2021138407A2
(en)
|
2020-01-03 |
2021-07-08 |
Marengo Therapeutics, Inc. |
Multifunctional molecules that bind to cd33 and uses thereof
|
|
US12213801B2
(en)
|
2020-10-02 |
2025-02-04 |
Cilag Gmbh International |
Surgical visualization and particle trend analysis system
|
|
US12580072B2
(en)
|
2020-10-02 |
2026-03-17 |
Cilag Gmbh International |
Cloud analytics packages
|
|
US11748924B2
(en)
|
2020-10-02 |
2023-09-05 |
Cilag Gmbh International |
Tiered system display control based on capacity and user operation
|
|
US11830602B2
(en)
|
2020-10-02 |
2023-11-28 |
Cilag Gmbh International |
Surgical hub having variable interconnectivity capabilities
|
|
US11877897B2
(en)
|
2020-10-02 |
2024-01-23 |
Cilag Gmbh International |
Situational awareness of instruments location and individualization of users to control displays
|
|
US11963683B2
(en)
|
2020-10-02 |
2024-04-23 |
Cilag Gmbh International |
Method for operating tiered operation modes in a surgical system
|
|
US11992372B2
(en)
|
2020-10-02 |
2024-05-28 |
Cilag Gmbh International |
Cooperative surgical displays
|
|
US12472032B2
(en)
|
2020-10-02 |
2025-11-18 |
Cilag Gmbh International |
Monitoring of user visual gaze to control which display system displays the primary information
|
|
US11672534B2
(en)
|
2020-10-02 |
2023-06-13 |
Cilag Gmbh International |
Communication capability of a smart stapler
|
|
US12016566B2
(en)
|
2020-10-02 |
2024-06-25 |
Cilag Gmbh International |
Surgical instrument with adaptive function controls
|
|
US12064293B2
(en)
|
2020-10-02 |
2024-08-20 |
Cilag Gmbh International |
Field programmable surgical visualization system
|
|
US12484897B2
(en)
|
2020-10-02 |
2025-12-02 |
Cilag Gmbh International |
Surgical instrument with adaptive configuration control
|
|
CN116948029A
(zh)
|
2022-04-20 |
2023-10-27 |
南京融捷康生物科技有限公司 |
一种包含IgG类Fc区变体的抗体及其用途
|